PremiumCompany AnnouncementsSoligenix Repays Loan, Boosting Financial Flexibility Biotech Alert: Searches spiking for these stocks today Biotech Alert: Searches spiking for these stocks today PremiumThe FlySoligenix initiates Phase 2 clinical trial of SGX945 in Behcet’s Disease Soligenix reports Q3 EPS (78c) vs. ($2.56) last year Soligenix granted Hong Kong patent for production of synthetic hypericin PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Morning Movers: Iteris skyrockets following take-private agreement Soligenix reports Q2 EPS ($1.31) vs ($3.56) last year 
